Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02213107
Title Enzalutamide & Dutasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Rochester
Indications
Therapies
Age Groups: senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Rochester Rochester New York 14642 United States Details
Medical College of Wisconscin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field